Long-acting beta2-agonists for chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, October 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 20 tweets from 15 users, with an upper bound of 122,752 followers.

LABAs have no measurable effect on mortality or rate of decline of lung function. https://t.co/5fysQ4WCdU. @CochraneAirways 9/n

Long-acting beta2-agonists for chronic obstructive pulmonary disease.Cochrane Database Syst Rev2013 Oct15p10:CD010177　http://t.co/yGyQhI6GQr

T1E2A2 #EPOC moder/severa: LABAs reducen exacerbaciones y mejoran calidad vida, no la mortalidad. Vía @rincondesisifo http://t.co/kA8iXypHGm

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 16 additional tweets.